Unmet needs with antipsychotic treatment in schizophrenia and bipolar I disorder: patient perspectives from qualitative focus groups
Michael J. Doane(Alkermes (United States)), Dawn I. Velligan(The University of Texas at San Antonio Health Science Center), April Foster(GroundMetrics (United States)), Kimberly Raymond(GroundMetrics (United States)), Martha Sajatovic(University Hospitals of Cleveland), Julia Carpenter-Conlin(Alkermes (United States)), Kaitlin LaGasse(GroundMetrics (United States)), Michelle K. White(GroundMetrics (United States)), Leona Bessonova(Alkermes (United States)), Amy K. O’Sullivan(Alkermes (United States)), Cory Saucier(GroundMetrics (United States))
Cited by 18
Related Papers
Self-report measures of medication adherence behavior: recommendations on optimal use
|Translational Behavioral Medicine|2015|832
Beyond hypofrontality: A quantitative meta‐analysis of functional neuroimaging studies of working memory in schizophrenia
|Human Brain Mapping|2005|622
The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness.
|PubMed|2009|611
Why do psychiatric patients stop antipsychotic medication? A systematic review of reasons for nonadherence to medication in patients with serious mental illness
|Patient Preference and Adherence|2017|325
Collaborative Care for Bipolar Disorder: Part II. Impact on Clinical Outcome, Function, and Costs
|Psychiatric Services|2006|315